These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 26036543

  • 1. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
    Rathi M, Rajkumar V, Rao N, Sharma A, Kumar S, Ramachandran R, Kumar V, Kohli HS, Gupta KL, Sakhuja V.
    Transplant Proc; 2015 May; 47(4):1158-61. PubMed ID: 26036543
    [Abstract] [Full Text] [Related]

  • 2. Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
    Reddy YN, Abraham G, Sundaram V, Reddy PP, Mathew M, Nagarajan P, Mehra N, Ramachandran A, Ali AA, Reddy YN.
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1113-20. PubMed ID: 26586047
    [Abstract] [Full Text] [Related]

  • 3. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
    Agarwal SK, Bhowmik D, Mahajan S, Bagchi S.
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
    [Abstract] [Full Text] [Related]

  • 4. A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients.
    Hardinger KL, Bohl DL, Schnitzler MA, Lockwood M, Storch GA, Brennan DC.
    Transplantation; 2005 Jul 15; 80(1):41-6. PubMed ID: 16003231
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 15; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 6. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E, Delgado P, Alvarez A, Cobo M, Pérez L, González-Posada JM, Hortal L, Gallego R, García JJ, Checa M, Morales A, Salido E, Hernández D, Torres A.
    Nephrol Dial Transplant; 2008 Apr 15; 23(4):1436-41. PubMed ID: 18029372
    [Abstract] [Full Text] [Related]

  • 7. Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation.
    Wissing KM, Abramowicz D, Weekers L, Budde K, Rath T, Witzke O, Broeders N, Kianda M, Kuypers DRJ.
    Am J Transplant; 2018 Jul 15; 18(7):1726-1734. PubMed ID: 29337426
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up.
    Lee YJ, Kim B, Lee JE, Kim YG, Kim DJ, Kim SJ, Joh JW, Oh HY, Huh W.
    Transpl Int; 2010 Feb 15; 23(2):147-54. PubMed ID: 19744223
    [Abstract] [Full Text] [Related]

  • 9. New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?
    Santos AH, Chen C, Casey MJ, Womer KL, Wen X.
    Nephrol Dial Transplant; 2018 Jan 01; 33(1):177-184. PubMed ID: 29045704
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.
    Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415
    [Abstract] [Full Text] [Related]

  • 11. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.
    Ghisdal L, Bouchta NB, Broeders N, Crenier L, Hoang AD, Abramowicz D, Wissing KM.
    Transpl Int; 2008 Feb 27; 21(2):146-51. PubMed ID: 17971033
    [Abstract] [Full Text] [Related]

  • 12. Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period.
    Luan FL, Zhang H, Schaubel DE, Miles CD, Cibrik D, Norman S, Ojo AO.
    Am J Transplant; 2008 Sep 27; 8(9):1871-7. PubMed ID: 18786231
    [Abstract] [Full Text] [Related]

  • 13. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 14. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols.
    Treede H, Klepetko W, Reichenspurner H, Zuckermann A, Meiser B, Birsan T, Wisser W, Reichert B, Munich and Vienna Lung Transplant Group.
    J Heart Lung Transplant; 2001 May 15; 20(5):511-7. PubMed ID: 11343977
    [Abstract] [Full Text] [Related]

  • 15. New-Onset Diabetes After Transplantation: Comparison Between a Cyclosporine-Based and a Tacrolimus-Based Immunosuppressive Regimen.
    Zolota A, Miserlis G, Solonaki F, Tranda A, Antoniadis N, Imvrios G, Fouzas I.
    Transplant Proc; 2018 Dec 15; 50(10):3386-3391. PubMed ID: 30577210
    [Abstract] [Full Text] [Related]

  • 16. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 17. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
    Plischke M, Riegersperger M, Dunkler D, Heinze G, Kikić Ž, Winkelmayer WC, Sunder-Plassmann G.
    PLoS One; 2015 Nov 15; 10(8):e0135674. PubMed ID: 26270340
    [Abstract] [Full Text] [Related]

  • 18. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
    Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, Krom RA.
    Transplantation; 1996 Dec 15; 62(11):1588-92. PubMed ID: 8970613
    [Abstract] [Full Text] [Related]

  • 19. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
    Handisurya A, Kerscher C, Tura A, Herkner H, Payer BA, Mandorfer M, Werzowa J, Winnicki W, Reiberger T, Kautzky-Willer A, Pacini G, Säemann M, Schmidt A.
    PLoS One; 2016 Dec 15; 11(1):e0145319. PubMed ID: 26735686
    [Abstract] [Full Text] [Related]

  • 20. New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia.
    Sinangil A, Celik V, Barlas S, Sakaci T, Koc Y, Basturk T, Akin EB, Ecder T.
    Prog Transplant; 2016 Mar 15; 26(1):55-61. PubMed ID: 27136250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.